Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 25, 2019 Off

The Global Biopharmaceuticals Market is Projected to Grow by 8.7% Through to 2025 and Reach $446 Billion

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. The biopharmaceuticals market is driven…

June 25, 2019 Off

Cerus Corporation Announces Presentations Highlighting INTERCEPT Blood System at the 29th Regional Congress of the ISBT

By BusinessWire

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS) announced today that multiple abstracts featuring the INTERCEPT Blood System pathogen reduction technology, including four…

June 24, 2019 Off

Terns Pharmaceuticals Announces Exclusive Licensing and Collaboration Agreement with GENFIT to Develop and Commercialize Elafibranor in the Greater China Region

By BusinessWire

-GENFIT partnership expands Terns’ portfolio, adding a Phase 3 product with a complementary mechanism of action well-suited to combinations with…

June 24, 2019 Off

Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Top-Line Results from the SOLACE Trial in Noninfectious Anterior Uveitis

By BusinessWire

LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…

June 24, 2019 Off

Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer

By BusinessWire

HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that Eric…

June 24, 2019 Off

Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3 Platform Technology and Key Therapeutic Indications

By BusinessWire

U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates European Patent…

June 24, 2019 Off

Magenta Therapeutics Appoints Anne McGeorge to Board of Directors

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…

June 24, 2019 Off

Five Prime Therapeutics Appoints Lori Lyons-Williams to its Board of Directors

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…

June 24, 2019 Off

Cryptosporidiosis: Global Clinical Trials Review (H1, 2019)

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cryptosporidiosis Global Clinical Trials Review, H1, 2019” clinical trials has been added to ResearchAndMarkets.com’s offering. Cryptosporidiosis Global Clinical…

June 24, 2019 Off

Global Cancer Monoclonal Antibodies Market Outlook 2019-2024 – Trastuzumab (Herceptin) Expected to Hold a Significant Market Share

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cancer Monoclonal Antibodies Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…

Posts pagination

Previous 1 … 3,051 3,052 3,053 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine